Submission Tilte
Metabolic Reprogramming and Molecular Pharmacology: Innovations in Drug Discovery and Therapeutic Targeting
Submission Abstract:
Metabolic reprogramming is a hallmark of numerous diseases, including cancer, metabolic disorders, and
neurodegeneration. Understanding the intricate cell signaling pathways, transduction pathways, and omics-based
data is important for the development of novel pharmacological interventions. This special issue of Current Molecular Medicine
will be devoted to the current advances in drug targeting metabolic reprogramming with
an emphasis on genomics, proteomics, and metabonomics applications. We invite contributions on molecular
mechanisms of metabolic reprogramming, novel small-molecule therapeutics, pathway-specific inhibitors, and
next-generation computational approaches to drug action analysis. Original research articles, reviews, and
perspectives covering translational pharmacology and therapeutic interventions are welcome. By integrating
multi-omics approaches with cutting-edge pharmacology, this issue will offer a glimpse into new strategies for
precision medicine and targeted therapies.